These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36155987)

  • 21. Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial.
    Durbin AP; Pierce KK; Kirkpatrick BD; Grier P; Sabundayo BP; He H; Sausser M; Russell AF; Martin J; Hyatt D; Cook M; Sachs JR; Lee AW; Wang L; Coller BA; Whitehead SS
    Am J Trop Med Hyg; 2020 Aug; 103(2):855-863. PubMed ID: 32394880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.
    Low JG; Lee LS; Ooi EE; Ethirajulu K; Yeo P; Matter A; Connolly JE; Skibinski DA; Saudan P; Bachmann M; Hanson BJ; Lu Q; Maurer-Stroh S; Lim S; Novotny-Diermayr V
    Vaccine; 2014 Sep; 32(39):5041-8. PubMed ID: 25045806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection.
    Pearson MS; Bethony JM; Pickering DA; de Oliveira LM; Jariwala A; Santiago H; Miles AP; Zhan B; Jiang D; Ranjit N; Mulvenna J; Tribolet L; Plieskatt J; Smith T; Bottazzi ME; Jones K; Keegan B; Hotez PJ; Loukas A
    FASEB J; 2009 Sep; 23(9):3007-19. PubMed ID: 19380510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.
    Keitel WA; Potter GE; Diemert D; Bethony J; El Sahly HM; Kennedy JK; Patel SM; Plieskatt JL; Jones W; Deye G; Bottazzi ME; Hotez PJ; Atmar RL
    Vaccine; 2019 Oct; 37(43):6500-6509. PubMed ID: 31515141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children.
    Brückner S; Agnandji ST; Elias J; Berberich S; Bache E; Fernandes J; Loembe MM; Hass J; Lell B; Mordmüller B; Adegnika AA; Kremsner P; Esen M
    Vaccine; 2016 Oct; 34(44):5384-5390. PubMed ID: 27642131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Human Hookworm Vaccine.
    Hotez PJ; Diemert D; Bacon KM; Beaumier C; Bethony JM; Bottazzi ME; Brooker S; Couto AR; Freire Mda S; Homma A; Lee BY; Loukas A; Loblack M; Morel CM; Oliveira RC; Russell PK
    Vaccine; 2013 Apr; 31 Suppl 2(Suppl 2):B227-32. PubMed ID: 23598487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
    Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
    Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus.
    Zhan B; Perally S; Brophy PM; Xue J; Goud G; Liu S; Deumic V; de Oliveira LM; Bethony J; Bottazzi ME; Jiang D; Gillespie P; Xiao SH; Gupta R; Loukas A; Ranjit N; Lustigman S; Oksov Y; Hotez P
    Infect Immun; 2010 Apr; 78(4):1552-63. PubMed ID: 20145100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of the hookworm Na-ASP-2 vaccine candidate: characterization of humoral and cellular responses after vaccination in the Sprague Dawley rat.
    Fujiwara RT; Bethony J; Bueno LL; Wang Y; Ahn SY; Samuel A; Bottazzi ME; Hotez P; Mendez S
    Hum Vaccin; 2005; 1(3):123-8. PubMed ID: 17012856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths.
    Diemert DJ; Pinto AG; Freire J; Jariwala A; Santiago H; Hamilton RG; Periago MV; Loukas A; Tribolet L; Mulvenna J; Correa-Oliveira R; Hotez PJ; Bethony JM
    J Allergy Clin Immunol; 2012 Jul; 130(1):169-76.e6. PubMed ID: 22633322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.
    Thera MA; Coulibaly D; Kone AK; Guindo AB; Traore K; Sall AH; Diarra I; Daou M; Traore IM; Tolo Y; Sissoko M; Niangaly A; Arama C; Baby M; Kouriba B; Sissoko MS; Sagara I; Toure OB; Dolo A; Diallo DA; Remarque E; Chilengi R; Noor R; Sesay S; Thomas A; Kocken CH; Faber BW; Imoukhuede EB; Leroy O; Doumbo OK
    Malar J; 2016 Aug; 15(1):442. PubMed ID: 27577237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of the immunogenicity and safety of the Hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16/18 AS04-adjuvanted cervical cancer vaccine.
    Leroux-Roels G; Haelterman E; Maes C; Levy J; De Boever F; Licini L; David MP; Dobbelaere K; Descamps D
    Clin Vaccine Immunol; 2011 Sep; 18(9):1510-8. PubMed ID: 21734063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults.
    Song JY; Choi MJ; Noh JY; Choi WS; Cheong HJ; Wie SH; Lee JS; Woo GJ; Lee SH; Kim WJ
    Hum Vaccin Immunother; 2017 May; 13(5):1190-1197. PubMed ID: 27996363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine.
    Seid CA; Curti E; Jones RM; Hudspeth E; Rezende W; Pollet J; Center L; Versteeg L; Pritchard S; Musiychuk K; Yusibov V; Hotez PJ; Bottazzi ME
    Hum Vaccin Immunother; 2015; 11(6):1474-88. PubMed ID: 25905574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls.
    Pedersen C; Breindahl M; Aggarwal N; Berglund J; Oroszlán G; Silfverdal SA; Szüts P; O'Mahony M; David MP; Dobbelaere K; Dubin G; Descamps D
    J Adolesc Health; 2012 Jan; 50(1):38-46. PubMed ID: 22188832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults.
    Bethony JM; Simon G; Diemert DJ; Parenti D; Desrosiers A; Schuck S; Fujiwara R; Santiago H; Hotez PJ
    Vaccine; 2008 May; 26(19):2408-17. PubMed ID: 18396361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial.
    Wu UI; Hsieh SM; Lee WS; Wang NC; Kung HC; Ou TY; Chen FL; Lin TY; Chen YC; Chang SC
    Vaccine; 2017 Jul; 35(33):4099-4104. PubMed ID: 28668573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein.
    Gregson AL; Oliveira G; Othoro C; Calvo-Calle JM; Thorton GB; Nardin E; Edelman R
    PLoS One; 2008 Feb; 3(2):e1556. PubMed ID: 18253503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Small Molecules of the Infective Stage of Human Hookworm Using LCMS-Based Metabolomics and Lipidomics Protocols.
    Wangchuk P; Anderson D; Yeshi K; Loukas A
    ACS Infect Dis; 2021 Dec; 7(12):3264-3276. PubMed ID: 34767348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.